Download PDF
CC BY-NC-ND 4.0 · Yearb Med Inform 2023; 32(01): 111-114
DOI: 10.1055/s-0043-1768744
Section 2: Cancer Informatics
Synopsis

Cancer Informatics 2023: Data Sharing and Federating Learning Point Towards New Collaborative Opportunities

Jeremy L. Warner
1   Professor, Department of Medicine, Brown University, Providence, RI, USA
2   Director, Center for Clinical Cancer Informatics and Data Science, Legorreta Cancer Center, Brown University, Providence, RI, USA
,
Debra Patt
3   Vice President, Texas Oncology, Austin, TX, USA
,
Section Editors for the IMIA Yearbook Section on Cancer Informatics › Author Affiliations
› Further Information
   Permissions and Reprints

Summary

Objective: To summarize significant research contributions on cancer informatics published in 2022.

Methods: An extensive search using PubMed/MEDLINE was conducted to identify the scientific contributions published in 2022 that address topics in cancer informatics. The selection process comprised three steps: (i) ten candidate best papers were first selected by the two section editors, (ii) external reviewers from internationally renowned research teams reviewed each candidate best paper, and (iii) the final selection of three best papers was conducted by the editorial board of the Yearbook.

Results: The three selected best papers demonstrate advances in federated learning, drug synergy prediction, and utilization of clinical note data.

Conclusion: Cancer informatics continues to mature as a subfield of biomedical informatics. Applications of informatics methods to data sharing and federated approaches are especially notable in 2022.

Keywords

Neoplasms - informatics - health information technology - disparities


Publication History

Article published online:
26 December 2023

© 2023. IMIA and Thieme. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Aneja S, Avesta A, Xu H, Machado LO. Clinical Informatics Approaches to Facilitate Cancer Data Sharing. Yearb Med Inform 2023 Jul 6. doi: 10.1055/s-0043-1768721.
    PubMed
  • 2 Lamy J-B, Séroussi B, Griffon N, Kerdelhué G, Jaulent M-C, Bouaud J. Toward a formalization of the process to select IMIA Yearbook best papers. Methods Inf Med 2015;54(2):135–44. doi: 10.3414/ME14-01-0031.
    PubMed
  • 3 Pati S, Baid U, Edwards B, Sheller M, Wang SH, Reina GA, et al. Federated learning enables big data for rare cancer boundary detection. Nat Commun 2022 Dec 5;13(1):7346. doi: 10.1038/s41467-022-33407-5.
    PubMed
  • 4 Kuru HI, Tastan O, Cicek AE. MatchMaker: A Deep Learning Framework for Drug Synergy Prediction. IEEE/ACM Trans Comput Biol Bioinform 2022 Jul-Aug;19(4):2334-44. doi: 10.1109/TCBB.2021.3086702.
    PubMed
  • 5 Kondratieff KE, Brown JT, Barron M, Warner JL, Yin Z. Mining Medication Use Patterns from Clinical Notes for Breast Cancer Patients Through a Two-Stage Topic Modeling Approach. AMIA Annu Symp Proc 2022 May 23;2022:303-12.
    PubMed
  • 6 Fang H, Zhang Z, Zhou Y, Jin L, Yang Y. A greedy approach for mutual exclusivity analysis in cancer study. Biostatistics 2022 Jul 18;23(3):910-25. doi: 10.1093/biostatistics/kxab004.
    PubMed
  • 7 Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science 2013 Mar 29;339(6127):1546-58. doi: 10.1126/science.1235122.
    PubMed
  • 8 Zhang W, Xue Z, Li Z, Yin H. DCE-DForest: A Deep Forest Model for the Prediction of Anticancer Drug Combination Effects. Comput Math Methods Med 2022 Jun 9;2022:8693746. doi: 10.1155/2022/8693746.
    PubMed
  • 9 Kaczmarek E, Jamzad A, Imtiaz T, Nanayakkara J, Renwick N, Mousavi P. Multi-Omic Graph Transformers for Cancer Classification and Interpretation. Pac Symp Biocomput 2022;27:373-84.
    PubMed
  • 10 Pu L, Singha M, Ramanujam J, Brylinski M. CancerOmicsNet: a multi-omics network-based approach to anti-cancer drug profiling. Oncotarget 2022 May 19;13:695-706. doi: 10.18632/oncotarget.
    PubMed
  • 11 Zeng J, Cruz-Pico CX, Saridogan T, Abu Shufean M, Kahle M, Yang D, et al. Natural Language Processing-Assisted Literature Retrieval and Analysis for Combination Therapy in Cancer. JCO Clin Cancer Inform 2022 Jan;6:e2100109. doi: 10.1200/CCI.21.00109.
    PubMed
  • 12 Yu Z, Yang X, Dang C, Wu S, Adekkanattu P, Pathak J, George TJ, et al. A Study of Social and Behavioral Determinants of Health in Lung Cancer Patients Using Transformers-based Natural Language Processing Models. AMIA Annu Symp Proc 2022 Feb 21;2021:1225-33.
    PubMed
  • 13 Rogier A, Coulet A, Rance B. Using an Ontological Representation of Chemotherapy Toxicities for Guiding Information Extraction and Integration from EHRs. Stud Health Technol Inform 2022 Jun 6;290:91-5. doi: 10.3233/SHTI220038.
    PubMed